Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET Â | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025 18:00 ET Â | Source: Rackspace US, Inc. SAN ANTONIO,…
Vaxart Granted Extension by Nasdaq to Regain Compliance
August 29, 2025 08:00 ET Â | Source: Vaxart, Inc. - Company must…
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information…
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 17:06 ET Â | Source: Taysha Gene Therapies, Inc. DALLAS,…
Hawaii American Water Granted New Rates by Hawaii Public Utilities Commission
Increase Driven by Over $40 Million in Infrastructure InvestmentsHONOLULU--(BUSINESS WIRE)--The Hawaii Public…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET Â | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2025 16:28 ET Â | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA
SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET Â | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…